Skip to content

Clinical trials

Completed Metabolism, Inborn Errors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Status: Completed Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20042
20052
20065
20072
20082
20095
20112
20121
20133
20143
20152
20161
20174
20186
20196
20201
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)23
Kastle Therapeutics, LLC4
Regeneron Pharmaceuticals4
Alexion Pharmaceuticals, Inc.3
University of Lausanne3
Alnylam Pharmaceuticals2
Dr. Schär AG / SPA2
Duke University2
FDA Office of Orphan Products Development2
Fred Hutchinson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors87
Rare Diseases31
Genetic Diseases, Inborn24
Metabolic Diseases20
Porphyrias9
Lipid Metabolism Disorders7
Lipid Metabolism, Inborn Errors7
Lysosomal Storage Diseases7
Phenylketonurias7
Infant, Newborn, Diseases6

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.